NXTC Dividend: NextCure Inc Yield Insights

Son mali tabloya (Form-10K) göre, NextCure Inc'in toplam varlıkları $80 olup, net loss $-56'dir.

NextCure Inc'in cari oranı 5.33, net kâr marjı 0, hisse başına satış $0'dir.

Currently NextCure Inc data is not available.

no, son mali tablolara göre NextCure Inc'in net loss $-56'dir.

yes, NextCure Inc'in yükümlülüğü 15'dir.

NextCure Inc'in toplam tedavüldeki hisse sayısı 2.33'dir.

Income

Balance sheet

Cash flow

Annual

Quarterly

NXTC Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	22
Revenue Growth (YoY)	--	--	--	--	-100%	267%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	14	16	20	21	20	17
Research & Development	48	--	47	54	50	46
Operating Expenses	63	57	68	75	70	63
Other Non Operating Income (Expenses)	2	4	0	--	--	--
Pretax Income	-60	-56	-63	-74	-69	-36
Income Tax Expense	--	--	--	--	--	--
Net Income	-60	-56	-63	-74	-69	-36
Net Income Growth	0%	-11%	-15%	7%	92%	9%
Shares Outstanding (Diluted)	2.37	2.33	2.31	2.31	2.3	2.29
Shares Change (YoY)	2%	0%	0%	0%	0%	75%
EPS (Diluted)	-25.65	-24.03	-27.15	-32.32	-30.15	-15.95
EPS Growth	-2%	-11%	-16%	7%	89%	-38%
Free Cash Flow	-54	-41	-53	-56	-59	-52
Free Cash Flow Per Share	-22.73	-17.59	-22.84	-24.22	-25.63	-22.66
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	-186.36%
Profit Margin	0%	0%	0%	0%	0%	-163.63%
Free Cash Flow Margin	0%	0%	0%	0%	0%	-236.36%
EBITDA	-61	-55	-65	-71	-66	-38
EBITDA Margin	0%	0%	0%	0%	0%	-172.72%
D&A For EBITDA	2	2	3	4	4	3
EBIT	-63	-57	-68	-75	-70	-41
EBIT Margin	0%	0%	0%	0%	0%	-186.36%
Effective Tax Rate	--	--	--	--	--	--